12-122226007-G-C

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_001371333.1(DIABLO):​c.8C>G​(p.Ala3Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00102 in 1,603,470 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A3V) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00076 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0010 ( 2 hom. )

Consequence

DIABLO
NM_001371333.1 missense

Scores

1
3
15

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 2.25

Publications

2 publications found
Variant links:
Genes affected
DIABLO (HGNC:21528): (diablo IAP-binding mitochondrial protein) This gene encodes an inhibitor of apoptosis protein (IAP)-binding protein. The encoded mitochondrial protein enters the cytosol when cells undergo apoptosis, and allows activation of caspases by binding to inhibitor of apoptosis proteins. Overexpression of the encoded protein sensitizes tumor cells to apoptosis. A mutation in this gene is associated with young-adult onset of nonsyndromic deafness-64. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, May 2013]
DIABLO Gene-Disease associations (from GenCC):
  • autosomal dominant nonsyndromic hearing loss 64
    Inheritance: AD Classification: MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia
  • autosomal dominant nonsyndromic hearing loss
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • nonsyndromic genetic hearing loss
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.013210952).
BP6
Variant 12-122226007-G-C is Benign according to our data. Variant chr12-122226007-G-C is described in ClinVar as [Likely_benign]. Clinvar id is 227298.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 116 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DIABLONM_001371333.1 linkc.8C>G p.Ala3Gly missense_variant Exon 1 of 6 ENST00000464942.7 NP_001358262.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DIABLOENST00000464942.7 linkc.8C>G p.Ala3Gly missense_variant Exon 1 of 6 1 NM_001371333.1 ENSP00000442360.2 Q9NR28-1
ENSG00000256861ENST00000535844.1 linkn.1594+6319C>G intron_variant Intron 12 of 15 2 ENSP00000454454.1 H3BMM5

Frequencies

GnomAD3 genomes
AF:
0.000762
AC:
116
AN:
152234
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000458
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00196
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000941
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000911
Gnomad OTH
AF:
0.00144
GnomAD2 exomes
AF:
0.000767
AC:
175
AN:
228220
AF XY:
0.000776
show subpopulations
Gnomad AFR exome
AF:
0.000292
Gnomad AMR exome
AF:
0.00166
Gnomad ASJ exome
AF:
0.00126
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000980
Gnomad OTH exome
AF:
0.000881
GnomAD4 exome
AF:
0.00104
AC:
1512
AN:
1451118
Hom.:
2
Cov.:
32
AF XY:
0.00101
AC XY:
730
AN XY:
721152
show subpopulations
African (AFR)
AF:
0.000210
AC:
7
AN:
33282
American (AMR)
AF:
0.00176
AC:
77
AN:
43690
Ashkenazi Jewish (ASJ)
AF:
0.00101
AC:
26
AN:
25834
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39378
South Asian (SAS)
AF:
0.00
AC:
0
AN:
84872
European-Finnish (FIN)
AF:
0.0000590
AC:
3
AN:
50856
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5322
European-Non Finnish (NFE)
AF:
0.00121
AC:
1345
AN:
1107966
Other (OTH)
AF:
0.000901
AC:
54
AN:
59918
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.461
Heterozygous variant carriers
0
89
178
268
357
446
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
54
108
162
216
270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000761
AC:
116
AN:
152352
Hom.:
0
Cov.:
32
AF XY:
0.000779
AC XY:
58
AN XY:
74502
show subpopulations
African (AFR)
AF:
0.000457
AC:
19
AN:
41580
American (AMR)
AF:
0.00196
AC:
30
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.0000941
AC:
1
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000911
AC:
62
AN:
68042
Other (OTH)
AF:
0.00142
AC:
3
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
6
13
19
26
32
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000872
Hom.:
0
Bravo
AF:
0.000842
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.000582
AC:
5
ExAC
AF:
0.000546
AC:
66
Asia WGS
AF:
0.000577
AC:
2
AN:
3478

ClinVar

Significance: Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 22, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Aug 03, 2017
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Ala3Gly in exon 2 of DIABLO: This variant is not expected to have clinical sig nificance because it has been identified in various populations with highest fre quencies in 0.16% (54/33120) of Latino chromosomes, 0.12% (12/9630) of Ashkenazi Jewish chromosomes, and 0.11% (107/113660) of European chromosomes by the Genom e Aggregation Database (gnomAD, http://gnomad.broadinstitute.org/; dbSNP rs20202 8496). -

DIABLO-related disorder Benign:1
Feb 20, 2024
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.15
BayesDel_addAF
Benign
-0.31
T
BayesDel_noAF
Benign
-0.24
CADD
Uncertain
24
DANN
Uncertain
0.99
DEOGEN2
Benign
0.16
T;T;.;.
Eigen
Benign
-0.050
Eigen_PC
Benign
-0.070
FATHMM_MKL
Benign
0.39
N
LIST_S2
Benign
0.72
T;.;T;T
M_CAP
Pathogenic
0.45
D
MetaRNN
Benign
0.013
T;T;T;T
MetaSVM
Benign
-0.59
T
MutationAssessor
Benign
1.7
L;L;L;.
PhyloP100
2.2
PrimateAI
Benign
0.38
T
PROVEAN
Benign
-1.3
N;.;N;.
REVEL
Uncertain
0.37
Sift
Uncertain
0.014
D;.;D;.
Sift4G
Benign
0.11
T;.;T;.
Polyphen
0.99
D;D;.;.
Vest4
0.28
MVP
0.79
MPC
0.083
ClinPred
0.061
T
GERP RS
3.7
PromoterAI
-0.27
Neutral
Varity_R
0.11
gMVP
0.50
Mutation Taster
=84/16
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.060
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs202028496; hg19: chr12-122710554; API